{"symbol": "AGLE", "companyName": "Aeglea BioTherapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.aegleabio.com", "description": "Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.", "CEO": "Anthony G. Quinn", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}